Comments on: Employees Sound Off on the Future of Genentech: 100% Roche? http://www.glassdoor.com/blog/employees-sound-off-on-the-future-of-genentech-100-roche/ Glassdoor - An Inside Look at Jobs and Companies Thu, 16 Feb 2012 16:08:02 +0000 hourly 1 http://wordpress.org/?v=3.2.1 By: Bank Of America Employees Sound Off Post Layoff News | Employer Branding Newshttp://www.glassdoor.com/blog/employees-sound-off-on-the-future-of-genentech-100-roche/comment-page-1/#comment-24667 Bank Of America Employees Sound Off Post Layoff News | Employer Branding News Mon, 26 Sep 2011 18:06:23 +0000 http://www.glassdoor.com/blog/?p=1018#comment-24667 [...] Employees Sound Off on the Future of Genentech: 100% Roche? [...] [...] Employees Sound Off on the Future of Genentech: 100% Roche? [...]

]]> By: Roche and Genentech Seal the Deal | Glassdoor.com Bloghttp://www.glassdoor.com/blog/employees-sound-off-on-the-future-of-genentech-100-roche/comment-page-1/#comment-10299 Roche and Genentech Seal the Deal | Glassdoor.com Blog Wed, 15 Jul 2009 01:19:19 +0000 http://www.glassdoor.com/blog/?p=1018#comment-10299 [...] See what other employees had to say in the days leading up to the final bid. [...] [...] See what other employees had to say in the days leading up to the final bid. [...]

]]> By: Topics about Go-greener » Blog Archive » Employees Sound Off on the Future of Genentech: 100% Roche?http://www.glassdoor.com/blog/employees-sound-off-on-the-future-of-genentech-100-roche/comment-page-1/#comment-6415 Topics about Go-greener » Blog Archive » Employees Sound Off on the Future of Genentech: 100% Roche? Sun, 03 May 2009 07:30:47 +0000 http://www.glassdoor.com/blog/?p=1018#comment-6415 [...] consumer-reports.ca added an interesting post today on Employees Sound Off on the Future of Genentech: 100% Roche?Here’s a small readingIt is hard to determine whether Roche will be able to provide a similar environment especially in the current economy. [...] [...] consumer-reports.ca added an interesting post today on Employees Sound Off on the Future of Genentech: 100% Roche?Here’s a small readingIt is hard to determine whether Roche will be able to provide a similar environment especially in the current economy. [...]

]]> By: What We’re Reading | On the Radar...http://www.glassdoor.com/blog/employees-sound-off-on-the-future-of-genentech-100-roche/comment-page-1/#comment-3583 What We’re Reading | On the Radar... Sat, 07 Mar 2009 00:35:52 +0000 http://www.glassdoor.com/blog/?p=1018#comment-3583 [...] Genentech is known. Despite an increasing blurring in the line between big biotech and pharma, this post from Glassdoor Blog provides some arguments and employee perspectives that Genentech still is [...] [...] Genentech is known. Despite an increasing blurring in the line between big biotech and pharma, this post from Glassdoor Blog provides some arguments and employee perspectives that Genentech still is [...]

]]> By: jmhttp://www.glassdoor.com/blog/employees-sound-off-on-the-future-of-genentech-100-roche/comment-page-1/#comment-3545 jm Thu, 05 Mar 2009 03:58:44 +0000 http://www.glassdoor.com/blog/?p=1018#comment-3545 i could be wrong...but I believe Franz Humer is no long CEO, but just chairman of the board at Roche....He left CEO July of 2008...Severin Schwan is the new CEO...Either way, Art Levinson has played this game of poker with the swiss before and he definitely has the upper hand....especially now that Roche has raised all this money in the bond market...after today's bond offering....Roche has now nealry $49 billion in cash equivalents.This pretty much solidifies a higher bid price....nearer the proposal from Genentech.Roche is so bad at this. They go to the bond market just days after Art Levinson et al. demonstrated the big "no thanks we want more"Roche is basically telegraphing that they are at least back to where they were in July of last year... i could be wrong…but I believe Franz Humer is no long CEO, but just chairman of the board at Roche….He left CEO July of 2008…

Severin Schwan is the new CEO…

Either way, Art Levinson has played this game of poker with the swiss before and he definitely has the upper hand….especially now that Roche has raised all this money in the bond market…after today’s bond offering….Roche has now nealry $49 billion in cash equivalents.

This pretty much solidifies a higher bid price….nearer the proposal from Genentech.

Roche is so bad at this. They go to the bond market just days after Art Levinson et al. demonstrated the big “no thanks we want more”

Roche is basically telegraphing that they are at least back to where they were in July of last year…

]]>